Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Interferon alfa-2b vaginal effervescent tablet
- Development stage
- Phase 4
- Lead developer
- Kawin Technology
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Administration
- Vaginal
01
Overview
Recombinant Human Interferon alfa-2b Vaginal Effervescent Tablet is a biologic drug developed and marketed by Beijing Kawin Technology. The active ingredient is recombinant human interferon alfa-2b, formulated as a vaginal effervescent tablet containing 0.5 million international units (MIU) per tablet. The drug is a recombinant protein that works by stimulating antiviral immune responses at the mucosal site through interferon-alpha's immunomodulatory mechanisms. It is specifically indicated for the treatment of cervical erosion caused by viral infection and for the prevention and treatment of human papillomavirus (HPV) infection. The product is administered locally by placing one tablet into the vaginal dome, typically once every other day.
- Other names
- Recombinant Human Interferon alfa-2b Vaginal Effervescent TabletInterferon alfa-2b (vaginal formulation)
02
Targets
IFNAR1 (Interferon alpha/beta receptor 1)IFNAR2 (Interferon alpha/beta receptor subunit 2)
Beyond the preview
Go deeper on Interferon alfa-2b vaginal effervescent tablet.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Interferon alfa-2b vaginal effervescent tablet.